GALT logo
GALT

Galectin Therapeutics Inc

Biotechnology

Galectin Therapeutics Inc (GALT) Earnings

Last reported
May 18, 2026
EPS estimate
-$0.06
EPS actual
—
Revenue est.
—
Revenue actual
—